G

GH Research PLC

GHRS

12.650
USD
0.19
(1.52%)
مغلق
حجم التداول
1,455
الربح لكل سهم
0
العائد الربحي
0
P/E
-12
حجم السوق
426,630,789
الأخبار المقالات

العنوان: GH Research PLC

القطاع: Healthcare
الصناعة: Biotechnology
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.